Alpa Laboratories Ltd.

₹63.88

0.9 (1.4%)

ALPA Share Price

Pharmaceuticals & Biotechnology

As on January 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 133 Cr

P/E Ratio6.89

Dividend YieldN/A

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	63.74	Bullish
10-DMA	66.79	Bearish
20-DMA	71.88	Bearish
50-DMA	76.37	Bearish
100-DMA	83.47	Bearish
200-DMA	92.87	Bearish

Historical Performance

1 Year

-42.4%

3 Years

0.4%

5 Years

78.4%

10 Years

6.5%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	1,125	1,087	930	1,123	976
Total Expenditure	1,077	1,006	849	1,016	899
Other Income	233	149	94	108	44
Operating Profit	281	230	174	214	121
Interest	2	4	2	2	1
Depreciation	22	20	13	17	12
Profit Before Tax	257	207	159	196	108
Consolidated Net Profit	195	168	126	141	72
Adjusted EPS	9	8	6	7	3

Compounded Sales Growth

10 Years:16

5 Years:5.5

3 Years:0

TTM:0.7

Compounded Profit Growth

10 Years:23.3

5 Years:60.1

3 Years:6.7

TTM:3.1

Stock Price CAGR

10 Years:0.5

5 Years:12.1

3 Years:0.1

TTM:-44.6

Return on Equity

10 Years:3.3

5 Years:3.4

3 Years:6

last year:9.3

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	210	210	210	210	210
Total Reserves	1,504	1,309	1,135	1,007	866
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	45	24	31	47	2
Other Current Liabilities	224	97	109	89	58
Short Term Borrowings	---	45	---	23	---
Total Liabilities	2,226	1,824	1,673	1,552	1,404
Capital Work in Progress	---	---	---	---	16
Long Term Loans & Advances	7	5	14	2	2
Currents Investments	1,105	911	720	687	407
Short Term Loans and Advances	134	127	58	95	155
Total Current Assets	1,925	1,610	1,491	1,380	1,211
Total Assets	2,226	1,824	1,673	1,552	1,404
Adjusted Book Value	81	72	64	58	51

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of 6.89, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of 0.7%, indicating poor shareholder returns.
The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹281 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1125 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 554177.1

No. of Shares: 8675 (Approx)

Performance:-44.6%

P/L: ₹-445822.9

NIFTY Performance: 9.4%

1 day Top Gainers